Department of psychiatry, Korea University Ansan Hospital, Gojan 1-dong, Danwon-gu, Ansan, Gyeonggi-do 152-703, Republic of Korea.
Prog Neuropsychopharmacol Biol Psychiatry. 2011 Dec 1;35(8):1938-43. doi: 10.1016/j.pnpbp.2011.07.015. Epub 2011 Aug 5.
We evaluated the efficacy of bimodal repetitive transcranial magnetic stimulation (rTMS) in treating pharmacologically non-responsive patients with schizophrenia.
Ten patients with DSM-IV schizophrenia, unresponsive to pharmacological treatment, underwent treatment with 15 rTMS sessions, as an adjunctive therapy, for three weeks. Each session comprised 40 trains, beginning every 30s: 20 trains of 10 Hz rTMS to the left dorsolateral prefrontal cortex (DLPFC) with a 3-s duration and 20 trains of 1 Hz rTMS to the left temporoparietal cortex (TPC) with a 30-s duration. We assessed patients via the Positive and Negative Syndrome Scale (PANSS) and Korean Version of the Calgary Depression Scale for Schizophrenia (K-CDSS), at five time points: baseline, Days 8, 15, and 22, and 1 week after final treatment (Day 29). Patients who agreed to take neurocognitive tests underwent neurocognitive function evaluations at baseline and 1 week after final treatment.
At Day 29, all PANSS subscale scores in had decreased significantly compared to baseline (Z=-2.214, p=0.027, positive; Z=-2.132, p=0.033, negative; Z=-2.023, p=0.043, general pathology; Z=-2.371, p=0.018, total). Effect over time was significant for the PANSS positive and negative subscale scores and total score (χ(2)=13.35, p=0.010; χ(2)=10.27, p=0.036; and χ(2)=16.50, p=0.002, respectively) but not for the general pathology subscale. Among the neurocognitive tests, the fourth and fifth trials and total K-AVLT scores showed significant increases (Z=-2.041, p=0.041; Z=-2.251, p=0.024; and Z=-2.201, p=0.028, respectively), suggesting improvement in short-term auditory verbal memory.
Bimodal rTMS stimulation of left DLPFC and left TPC induced clinical improvement in pharmacologically non-responsive schizophrenia patients and may have improved their short-term verbal memories.
我们评估了双模式重复经颅磁刺激(rTMS)治疗药物反应不佳的精神分裂症患者的疗效。
10 名符合 DSM-IV 精神分裂症标准、对药物治疗无反应的患者接受了为期 3 周的 15 次 rTMS 治疗,作为辅助治疗。每个疗程包括 40 个疗程,每隔 30 秒开始一次:左背外侧前额叶(DLPFC)进行 10 Hz rTMS 20 个疗程,持续 3 秒,左颞顶叶皮层(TPC)进行 1 Hz rTMS 20 个疗程,持续 30 秒。我们在五个时间点通过阳性和阴性综合征量表(PANSS)和韩国版卡尔加里精神分裂症抑郁量表(K-CDSS)评估患者:基线、第 8、15、22 天和最后一次治疗后 1 周(第 29 天)。同意接受神经认知测试的患者在基线和最后一次治疗后 1 周进行神经认知功能评估。
第 29 天,所有 PANSS 分量表评分均较基线显著下降(Z=-2.214,p=0.027,阳性;Z=-2.132,p=0.033,阴性;Z=-2.023,p=0.043,一般病理;Z=-2.371,p=0.018,总分)。PANSS 阳性和阴性分量表评分及总分的时间效应有统计学意义(χ(2)=13.35,p=0.010;χ(2)=10.27,p=0.036;χ(2)=16.50,p=0.002),但一般病理分量表无统计学意义。在神经认知测试中,第四次和第五次试验及 K-AVLT 总分均显著增加(Z=-2.041,p=0.041;Z=-2.251,p=0.024;Z=-2.201,p=0.028),提示短期听觉言语记忆改善。
左 DLPFC 和左 TPC 的双模式 rTMS 刺激可改善药物反应不佳的精神分裂症患者的临床症状,并可能改善其短期言语记忆。